Investigating how RNA binding proteins affect tau-related dementia
The Role of RNA Binding Protein Networks in Tauopathy and Related Dementia
This study is looking at how certain proteins in our cells might affect the development of Alzheimer's and similar diseases, and it needs patient samples to help figure out how these proteins can lead to problems with tau, a protein linked to dementia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10875751 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of RNA binding proteins (RBPs) in the development of tauopathies, which are neurodegenerative diseases like Alzheimer's. By analyzing patient samples and using advanced mouse models, the researchers aim to uncover how disruptions in RBP networks lead to abnormal tau protein behavior, contributing to dementia. The study employs a combination of bioinformatics, molecular techniques, and RNA sequencing to identify key RBPs involved in these processes. Patients may provide samples to help validate the findings and contribute to a better understanding of dementia.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with Alzheimer's disease or related dementias, as well as those willing to provide biological samples.
Not a fit: Patients with non-neurodegenerative conditions or those without a diagnosis of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown promising results in understanding the role of RNA binding proteins in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Vassar, Robert J — Northwestern University at Chicago
- Study coordinator: Vassar, Robert J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.